Toscana Biomarkers

• it
• en

• Company
  • • Investors
    • Management
    • Scientific Board
    • Staff
    • Grants and collaborations
• Research

  • Research

    In the process leading to the commercialization of in vitro diagnostic tests, Toscana Biomarkers is involved in finding serological markers and developing pre-competitive tests.

  • • MS Multiple Sclerosis
    • RA Rheumatoid Arthritis
    • SLE Systemic Lupus Erythematosus
    • NMO Neuromyelitis Optica
    • CU Chronic Urticaria
• Products

  • Products

    Our mission is the identification of specific biomarkers in patients sera in order to set up in vitro assays to support diagnosis and therapeutic treatments.

  • • Biomarkers
    • Diagnostic test
• Support
  • • Literature and Patents
• Technology

• Contacts
• News

Home > Company > Grants and collaborations

Grants and collaborations

Active grants

MARK

Granted by Regione Toscana: POR FESR 2007 – 2013 activity 1.1 line C, to support projects based on joint industrial research and experimental development of small and medium-size enterprises and research organizations in the field of Health.

Title: “Identification of diagnostic biomarkers for immune-mediated diseases.” Participants: Toscana Biomarkers (coordinator), University of Firenze and Pisa.

ALLFUN

Funded by European Committee, Seventh Framework Programme (FP7): HEALTH-2010.2.4.5-2 - Collaborative Project Small or medium-scale focused research project.

Title: “Fungi in the setting of inflammation, allergy and autoimmune diseases: Translating basic science into clinical practices”. Toscana Biomarkers and other 12 participants are involved.

Collaborations

DIESSE RICERCHE, Siena

2011: Development of diagnostic kits for multiple sclerosis and rheumatoid arthritis

INODIAG, Marseille, France

2011: Development of diagnostic tests for rheumatoid arthritis based on MUST (MUltiplex Serology Test) technology

QUANTISCIENTIFICS, Irvine, CA, USA

2010: Development of multiplex diagnostic tests based on microarray A2TM technology